Der Chirurg

, Volume 77, Issue 4, pp 325–334 | Cite as

Zentrale Gallengangskarzinome

  • H. Lang
  • G. M. Kaiser
  • T. Zöpf
  • G. C. Sotiropoulos
  • A. Frilling
  • M. Malagó
  • C. E. Broelsch
Leitthema

Zusammenfassung

Die R0-Resektion stellt derzeit die einzige potenziell kurative Therapieform des zentralen Gallengangskarzinoms dar. Die besondere anatomische Lokalisation der Tumoren mit unmittelbarer Nähe zu Leberarterie und Pfortader setzt dabei jedoch operationstechnische Grenzen und schränkt die Übertragbarkeit der Prinzipien der onkologischen Chirurgie ein. Lokale Resektionsverfahren wie die Hepatikusgabelresektion allein oder in Kombination mit limitierten Leberresektionen können mit geringer Morbidität und Mortalität durchgeführt werden, gehen aber mit einer hohen Lokalrezidivrate einher. Ausreichende Sicherheitsabstände können meistens nur durch ausgedehnte Leberresektionen erreicht werden. Die erweiterte Hemihepatektomie rechts („right trisectionectomy“) erlaubt eine weitgehend tumorferne Präparation und ermöglicht die potenziell größten tumorfreien Resektionsränder. Die berichteten 5-Jahre-Überlebensraten liegen zwischen 20% und 40%, in selektionierten Untergruppen sogar bis zu 59%. Die Verfügbarkeit neuer onkologischer Therapieprotokolle sowie insbesondere die Möglichkeit der Leberlebendspende könnten dafür sprechen, dass die Rolle der Lebertransplantation bei diesem Krankheitsbild neu zu definieren ist.

Schlüsselwörter

Klatskin-Tumor Hiläres Gallengangskarzinom Zentrales Gallengangskarzinom Leberresektion 

Surgical therapy of hilar cholangiocarcinoma

Abstract

Surgical resection provides the only chance of cure for patients suffering from hilar cholangiocarcinoma. Due to the central anatomic localization within the liver hilum, established guidelines of oncologic surgery are difficult to apply. Resection of the hilar bifurcation alone or in combination with limited hepatic resection can be performed with low morbidity and low mortality but shows a high rate of local tumor recurrence. Usually, extended resection is required to achieve adequate safety margins. Right trisectionectomy complies best with the basic rules of oncologic surgery while allowing the maximum safety margin. The 5-year survival rates reported after right trisectionectomy range between 20% and 40% and reach 59% in selected patients. The increasing experience with living donor transplantation and recent advances in neoadjuvant tumor therapy may lead to renewed discussion of liver transplantation in hilar cholangiocarcinoma.

Keywords

Hilar cholangiocarcinoma Klatskin’s tumor Central bile duct carcinoma Liver resection 

Notes

Interessenkonflikt

Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.

Literatur

  1. 1.
    Altemeier WA, Gall EA, Zinninger MM, Hoxworth PI (1957) Sclerosing carcinoma of the major intrahepatic bile ducts. Arch Surg 75: 450–461Google Scholar
  2. 2.
    Beazley RM, Hadjis N, Benjamin IS et al. (1984) Clinicopathological aspects of high bile duct cancer: experience with resection and bypass surgical treatments. Ann Surg 199: 623–636PubMedGoogle Scholar
  3. 3.
    Becker T, Lehner F, Bektas H, Meyer A (2003) Chirurgische Therapie hilärer Gallengangskarzinome (Klatskin-Tumoren). Zentralbl Chir 128: 928–935CrossRefPubMedGoogle Scholar
  4. 4.
    Beckurts KTE, Hölscher AH, Bauer TH, Siewert JR (1997) Maligne Tumoren der Hepaticusgabel – Ergebnisse der chirurgischen Therapie und Prognosefaktoren. Chirurg 68: 378–384CrossRefPubMedGoogle Scholar
  5. 5.
    Belghiti J, Ogata S (2005) Preoperative optimization of the liver for resection in patients with hilar cholangiocarcinoma. HPB 7: 252–253Google Scholar
  6. 6.
    Bismuth H, Corlette MB (1975) Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 140: 170–178PubMedGoogle Scholar
  7. 7.
    Bismuth H, Nakache R, Diamond T (1992) Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 215: 31–38PubMedGoogle Scholar
  8. 8.
    Chang WH, Kortan P, Haber GB (1998) Outcome in patients with bifurcation tumours who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc 47: 354–362CrossRefPubMedGoogle Scholar
  9. 9.
    Dinant S, Gerhards MF, Busch ORC et al. (2005) The importance of complete excision of the caudate lobe in resection of hilar cholangiocarcinoma. HPB 7: 263–267Google Scholar
  10. 10.
    Domagk D, Poremba C, Dietl KH et al. (2002) Endoscopic transpapillary biopsies and ultraductal ultrasonography in the diagnosis of bile duct strictures: a prospective study. Gut 51: 240–244CrossRefPubMedGoogle Scholar
  11. 11.
    Ebata T, Watanabe H, Ajioka Y et al. (2002) Pathological appraisal of lines of resection for bile duct carcinoma. Br J Surg 89: 1260–1267CrossRefPubMedGoogle Scholar
  12. 12.
    Heimbach JK, Gores GJ, Haddock MG et al. (2004) Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 24: 201–207CrossRefPubMedGoogle Scholar
  13. 13.
    Hemming AW, Read AI, Fujita S et al. (2005) Surgical management of hilar cholangiocarcinoma. Ann Surg 241: 693–702CrossRefPubMedGoogle Scholar
  14. 14.
    Iwatsuki S, Todo S, Marsh JW et al. (1998) Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 187: 358–364CrossRefPubMedGoogle Scholar
  15. 15.
    Jarnagin WR, Fong Y, DeMatteo RP et al. (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234: 507–517CrossRefPubMedGoogle Scholar
  16. 16.
    Jarnagin WR, Ruo L, Little SA et al. (2003) Patterns of initial disease recurrence after resection of gallbladder Carcinoma and hilar cholangiocarcinoma. Cancer 98: 1689–1700CrossRefPubMedGoogle Scholar
  17. 17.
    Jonas S, Mittler J, Pascher A et al. (2005) Extended indications in living-donor liver transplantation: bile duct cancer. Transplantation 80: 101–104CrossRefGoogle Scholar
  18. 18.
    Jonas S, Steinmüller T, Neuhaus P (2001) Chirurgische Therapie von Leberhilustumoren. Chirurg 72: 775–783CrossRefPubMedGoogle Scholar
  19. 19.
    Kaiser GM, Oldhafer KJ, Zhang HW et al. (2002) Treatment of nonresectable proximal bile duct carcinoma using intraoperative radiotherapy combined with hepatojejunostomy. J Surg Oncol 81: 55–57CrossRefPubMedGoogle Scholar
  20. 20.
    Kawasaki S, Imamura H, Kobayashi A et al. (2003) Results of surgical resection for patients with hilar bile duct cancer – application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 238: 84–92CrossRefPubMedGoogle Scholar
  21. 21.
    Kitagawa Y, Nagino M, Kamiya J et al. (2001) Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg 233: 385–392CrossRefPubMedGoogle Scholar
  22. 22.
    Klatskin G (1965) Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis: an unusual tumor with distinctive clinical and pathological features. Am J Med 38: 241–256CrossRefPubMedGoogle Scholar
  23. 23.
    Klempnauer J, Ridder GJ, von Wasielewski R et al. (1997) Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol 15: 947–954PubMedGoogle Scholar
  24. 24.
    Kluge R, Schmidt F, Caca K et al. (2001) Positron emission tomography with [(18)F]fluoro-2-desoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology 33: 1029–1035CrossRefPubMedGoogle Scholar
  25. 25.
    Knoefel WT, Prenzel KL, Peiper M et al. (2003) Klatskin tumors and Klatskin mimicking lesions of the biliary tree. Eur J Surg Oncol 29: 658–661CrossRefPubMedGoogle Scholar
  26. 26.
    Kosuge T, Yamamoto J, Shimada K et al. (1999) Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 230: 663–671CrossRefPubMedGoogle Scholar
  27. 27.
    Kraus T, Herfarth C (2001) Chirurgische Therapie von Karzinomen der extrahepatischen Gallenwege und der Gallenblase. In: Siewert JR, Harder F, Rothmund M (eds) Praxis Viszeralchir 577–620Google Scholar
  28. 28.
    Lang H, Sotiropoulos GC, Malagó M, Broelsch CE (2003) Mesohepatectomy, caudate lobectomy and resection of hilar bifurcation with biliary reconstruction by 6 hepatico-jejunostomies for Klatskin tumor. Hepatogastroenterology 50: 1327–1329PubMedGoogle Scholar
  29. 29.
    Lang H, Sotiropoulos GC, Dömland M et al. (2005) Extended hepatectomy for intrahepatic Cholangiocellular carcinoma (ICC) – when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-years-period. Ann Surg 241: 134–143PubMedGoogle Scholar
  30. 30.
    Lang H, Sotiropoulos GC, Kaiser GM et al. (2005) The role of liver transplantation in the treatment of hilar cholangiocarcinoma. HPB 7: 278–282Google Scholar
  31. 31.
    Lee SG, Lee YJ, Park KM et al. (2000) One hundred and eleven liver resections for hilar bile duct cancer. J Hepatobiliary Pancreat Surg 7: 135–141CrossRefPubMedGoogle Scholar
  32. 32.
    Miyazaki M, Ito H, Nakagawa K et al. (1999) Parenchyma-preserving hepatectomy in the surgical treatment of hilar choalngiocarcinoma. J Am Coll Surg 189: 575–583CrossRefPubMedGoogle Scholar
  33. 33.
    Nagino M, Nimura Y, Kamiya J et al. (1995) Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery 117: 677–681PubMedGoogle Scholar
  34. 34.
    Nagino M, Kamiya J, Arai T et al. (2006) Anatomic right hepatic trisectionectomy (extended right hepatectomy) with caudate lobectomy for hilar cholangiocarcinoma. Ann Surg 243: 28–32CrossRefPubMedGoogle Scholar
  35. 35.
    Neuhaus P, Jonas S, Bechstein WO et al. (1999) Extended Resections for Hilar Cholangiocarcinoma. Ann Surg 230: 808–819CrossRefPubMedGoogle Scholar
  36. 36.
    Neuhaus P, Jonas S, Settmacher U et al. (2003) Surgical management of proximal bile duct cancer: extended right lobe resection increases respectability and radicality. Langenbecks Arch Surg 388: 194–200CrossRefPubMedGoogle Scholar
  37. 37.
    Nimura Y, Kamiya J, Kondo S et al. (2000) Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg 7: 155–162CrossRefPubMedGoogle Scholar
  38. 38.
    Nishio H, Hidalgo E, Hamady ZZR et al. (2005) Left hepatic trisectionectomy for hepatobiliary malignancy – results and an appraisal of its current role. Ann Surg 242: 267–275CrossRefPubMedGoogle Scholar
  39. 39.
    Nishio H, Nagino M, Nimura Y (2005) Surgical management of hilar cholangiocarcinoma: the Nagoya experience. HPB 7: 259–262Google Scholar
  40. 40.
    Ogura Y, Takahashi K, Tabata M, Mizumoto R (1994) Clinicopathological study on carcinoma of the extrahepatic bile duct with special focus on cancer invasion on the surgical margin. World J Surg 18: 778–784CrossRefPubMedGoogle Scholar
  41. 41.
    Otto G, Thies J, Hoppe-Lotichius M et al. (2004) Hiläres Cholangiokarzinom – Ergebnisse bei En-bloc-Resektion von Tumor und Leber. Chirurg 75: 59–65CrossRefPubMedGoogle Scholar
  42. 42.
    Pichlmayr R, Lehr L, Ziegler H (1983) Resektion hilusnaher Gallengangskarzinome statt palliativer Gallengangsdrainage. Langenbecks Arch Chir 359: 275–288CrossRefPubMedGoogle Scholar
  43. 43.
    Pichlmayr R, Weimann A, Klempnauer J et al. (1996) Surgical treatment in proximal bile duct cancer. Ann Surg 224: 628–638CrossRefPubMedGoogle Scholar
  44. 44.
    Reinhardt MJ, Strunk H, Gerhardt T et al. (2005) Detection of Klatskin‘s tumor in extrahepatic bile duct strictures using delayed 18-FDG PET/CT: preliminary results for 22 patient studies. J Nucl Med 46: 1158–1163PubMedGoogle Scholar
  45. 45.
    Romaneehsen B, Otto G, Lohse AW et al. (2004) Die Diagnostik des hilären Cholangiokarzinoms: Wertigkeit von präoperativer ERC, MRC und PTC im Vergleich zur Histopathologie. Fortschr Röntgenstr 176: 1750–1758Google Scholar
  46. 46.
    Sakamoto E, Nimura Y, Hayakawa N et al. (1998) The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg 227: 405–411CrossRefPubMedGoogle Scholar
  47. 47.
    Seyama Y, Kubota K, Sano K et al. (2003) Long-term outcome of extended hepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 238: 84–92CrossRefPubMedGoogle Scholar
  48. 48.
    Sewnath ME, Karsten TM, Prins MH et al. (2002) A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg 236: 17–27CrossRefPubMedGoogle Scholar
  49. 49.
    Shimada H, Endo I, Sugita M et al. (2003) Is parenchyma-preserving hepatectomy a noble option in the surgical treatment for high-risk patients with hilar bile duct cancer? Langenbeck‘s Arch Surg 388: 33–41Google Scholar
  50. 50.
    Sobin LH, Wittekind CH (2002) TNM Classification of malignant tumours. 6th edn. John Wiley & Sons Ltd, West SussexGoogle Scholar
  51. 51.
    Strasberg SM, Belghiti J, Clavien PA et al. (2000) The Brisbane 2000 terminology of liver anatomy and resections. HPB 2: 333–339Google Scholar
  52. 52.
    Tamada K, Nagai H, Yasuda Y et al. (2001) Transpapillary intraductal US prior to biliary drainage in the assessment of longitudinal spread of extrahepatic bile duct carcinoma. Gastrointest Endosc 53: 300–307PubMedGoogle Scholar
  53. 53.
    Tannapfel A, Wittekind C (2001) Anatomie und Pathologie des intrahepatischen und extrahepatischen Gallengangskarzinoms. Pathologe 21: 114CrossRefGoogle Scholar
  54. 54.
    Ten Hoopen-Neumann H, Gerhards MF, van Gulik TM et al. (1999) Occurence of implantation metastases after resection of Klatskin tumors. Dig Surg 16: 209–213CrossRefPubMedGoogle Scholar
  55. 55.
    Tojima Y, Nagino M, Ebata T et al. (2003) Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg 237: 201–207CrossRefPubMedGoogle Scholar
  56. 56.
    Wakai T, Shirai Y, Moroda T et al. (2005) Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer 103: 1210–1216CrossRefPubMedGoogle Scholar
  57. 57.
    Weber SM, DeMatteo RP, Fong Y et al. (2002) Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients. Ann Surg 235: 392–399CrossRefPubMedGoogle Scholar
  58. 58.
    Wiedmann M, Schoppmeyer K, Witzigmann H et al. (2005) Aktuelle Diagnostik und Therapie von Gallengangs- und Gallenblasenkarzinomen. Z Gastroenterol 43: 305–315CrossRefPubMedGoogle Scholar
  59. 59.
    Yamaguchi K, Chijiiwa K, Saiki S et al. (1997) Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications. Hepatogastroenterology 44: 1256–1261PubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag 2006

Authors and Affiliations

  • H. Lang
    • 1
  • G. M. Kaiser
    • 1
  • T. Zöpf
    • 2
  • G. C. Sotiropoulos
    • 1
  • A. Frilling
    • 1
  • M. Malagó
    • 1
  • C. E. Broelsch
    • 1
  1. 1.Klinik für Allgemein-, Viszeral- und TransplantationschirurgieUniversitätsklinikum EssenEssen
  2. 2.Klinik für Gastroenterologie und HepatologieUniversitätsklinikum EssenEssen

Personalised recommendations